Brief: VTV Therapeutics Got Letter From Nasdaq Notifying It Is Not In Compliance With A Listing Rule
19/12/2023 21:49
Dec 19 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS - ON DEC 13, CO GOT LETTER FROM NASDAQ
NOTIFYING CO THAT IT IS NOT IN COMPLIANCE WITH REQUIREMENT OF
NASDAQ LISTING RULE 5550(B)(2)
Source text for Eikon: ID:
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)